Exclusive

Publication

Byline

Location

CSIR-NAL develops non invasive ventilator

India, May 14 -- CSIR - National Aerospace Laboratories (NAL) Bangalore, a constituent of lab of CSIR has developed a Non Invasive BiPAP Ventilator in a record time of 36 days to treat COVID-19 patien... Read More


"Contactless technologies will gain prominence in the upcoming future"- Deepak NG

India, May 14 -- By when do you think India will become COVID-19 free? The COVID19 pandemic outbreak in India has had a widespread and unprecedented impact on people, businesses and economy. While, t... Read More


Cipla ties up with Gilead for manufacturing Remdesivir

India, May 14 -- Cipla has announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine Remdesivir... Read More


Cipla supports Siliguri in the fight against COVID-19

India, May 14 -- Cipla has announced a number of initiatives that it has undertaken to tackle the COVID-19 pandemic in Siliguri. The Company recently launched an INR 25 crore 'Caring for Life' COVID-1... Read More


Glenmark initiates Ph 3 trials on Favipiravir for COVID-19 in India

India, May 13 -- Glenmark Pharmaceuticals, a research-led integrated global pharmaceutical company, has initiated Phase 3 clinical trials inIndiaon Antiviral tablet Favipiravir, for which it received ... Read More


Jubilant inks licensing deal with Gilead for Remdesivir

India, May 13 -- Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, is pleased to announce that its subsidiary, Jubilant Generics Limited ("Jubilant"), has ... Read More


"We have diverted resources to supply reagents for COVID-19 testing kits"- Jonathan Hunt

India, May 13 -- "I am pleased to announce solid revenue growth of 13% in the fourth quarter against a strong corresponding quarter last year. The quarter saw our two main divisions; Discovery Service... Read More


Cipla enters into a licensing agreement With Gilead

India, May 13 -- Cipla has announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine Remdesivir... Read More


Merck granted U.S. Patents for Foundational CRISPR-Cas9 Technology

India, May 13 -- Merck, a leading science and technology company has announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States. These allowances prov... Read More


Merck receives US patents for CRISPR-Cas9 technology

India, May 13 -- Merck, a leading science and technology company has announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States. These allowances prov... Read More